Asthma is a chronic lung disease characterized by hyper responsiveness of tracheobronchial smooth muscle to stimuli, resulting in narrowing and inflammation of air tubes, accompanied by increased secretion, swelling and build-up of tissue fluid. Symptoms include tight chest, wheezing, cough and may be limitation of activity due to difficulty in breathing.
This report elaborates the market size, market characteristics, and market growth of the Anti-Asthmatic Drugs industry, and breaks down according to the type, application, and consumption area of Anti-Asthmatic Drugs. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Anti-Asthmatic Drugs in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Anti-Asthmatic Drugs market covered in Chapter 13:
Sunovion Pharmaceuticals Inc
Novartis International AG
Teva Pharmaceutical Industries
F. Hoffmann-La Roche Ltd
Merck & Co., Inc.
In Chapter 6, on the basis of types, the Anti-Asthmatic Drugs market from 2015 to 2025 is primarily split into:
In Chapter 7, on the basis of applications, the Anti-Asthmatic Drugs market from 2015 to 2025 covers:
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
Europe (Covered in Chapter 9)
Asia-Pacific (Covered in Chapter 10)
Middle East and Africa (Covered in Chapter 11)
South America (Covered in Chapter 12)
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025